Summit
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (13)
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Started: 11/18/2025
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Started: 2/27/2025
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Started: 10/26/2023
Phase III Study of AK112 for NSCLC Patients
Started: 5/4/2023
Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects
Started: 5/19/2021
Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
Started: 1/28/2019
A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
Started: 9/10/2026
Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD)
Started: 6/1/2016
A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI)
Started: 12/1/2014
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
Started: 4/1/2014
A Clinical Study of Ivonescimab in Combination With Cadonilimab or Ipilimumab for Advanced Renal Cancer
Started: 10/19/2026
Modified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced Diet
Started: 2/1/2015
A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD)
Started: 11/1/2013